Bosentan
Links shared publicly online about this topic
New study finds no significant benefit of bosentan against IPF
news-medical.net — “A new study has demonstrated no significant benefit of taking the drug bosentan for idiopathic pulmonary fibrosis.” View full resource at news-medical.net
Most Recently Shared on April 11, 2011 at 5:46 am By:
New study finds no significant benefit of bosentan against IPF: A new study has demonstrated no significant bene... http://bit.ly/eFRDKS
First Report of the Successful Use of Bosentan in Refractory Vasospastic Angina
content.karger.com — “Variant angina is caused by focal spasm of the epicardial coronary arteries and is variably associated with atherosclerotic coronary disease. We present the clinical course of profound coronary spasm in a woman which resulted in life-threatening symptoms. Although not previously reported, administration of the endothelin antagonist bosentan resulted in complete resolution of her symptoms which were refractory to commonly used anti-anginals, and these symptoms recurred when the drug was inadverte” View full resource at content.karger.com
Most Recently Shared on August 9, 2010 at 9:45 pm By:
Symposier Cardiology Cardiology and Health Business
First Report of the Successful Use of Bosentan in Refractory Vasospastic Angina. http://bit.ly/d38Ifb
Bosentan Reduced Occurrence of Digital Ulcers in Systemic Sclerosis : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on September 20, 2010 at 8:39 pm By:
Skin & Allergy News Health News
#Bosentan Reduced Occurrence of Digital Ulcers in Systemic #Sclerosis, reported by Diana Mahoney for SAN:http://bit.ly/c9sRDB
Medical News: No Exercise Benefit with Bosentan in Systemic Sclerosis - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “Treatment with the endothelin receptor antagonist bosentan failed to improve exercise capacity in patients with systemic sclerosis, a randomized trial found.” View full resource at medpagetoday.com
Most Recently Shared on July 10, 2010 at 4:23 pm By:
No Exercise Benefit with Bosentan in Systemic Sclerosis (CME/CE) http://ow.ly/184XAl
Successful bosentan therapy for pulmonary arterial hypertension... http://hub.am/eTnUlr
blog.mdlinx.com — “Successful bosentan therapy for pulmonary arterial hypertension... http://hub.am/eTnUlr” View full resource at blog.mdlinx.com
Most Recently Shared on December 20, 2010 at 1:41 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Successful bosentan therapy for pulmonary arterial hypertension... http://hub.am/eTnUlr
Bosentan Helps Prevent Hand Ulcers (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A multinational clinical trial found that treatment with the endothelin receptor antagonist bosentan (Tracleer) showed some benefit in preventing new digital ulcers in patients with systemic sclerosis.” View full resource at qualitypointtech.net
Most Recently Shared on September 9, 2010 at 1:52 pm By:
Bosentan Helps Prevent Hand Ulcers (CME/CE): (MedPage Today) -- A multinational clinical trial found that treatmen... http://bit.ly/bHqlCV
Bosentan May Reduce Skin Fibrosis in Scleroderma : Skin & Allergy News
skinandallergynews.com — “Skin & Allergy News Digital Network is the online destination and multimedia properties of Skin & Allergy News, the independent news publication for the dermatology community. Our breaking news covers all areas of medical dermatology, dermatologic surgery, and aesthetic dermatology. We also provide the news by specialty interest: acne and rosacea, atopic dermatitis and eczema, cutaneous oncology, hair and nails, infectious diseases, pediatric dermatology, psoriasis and rheumatologic disorders, s” View full resource at skinandallergynews.com
Most Recently Shared on June 9, 2011 at 3:09 pm By:
Miriam E. Tucker Patient Expert
RT @sknews: Bosentan May Reduce Skin Fibrosis in Scleroderma http://bit.ly/moqjgx
Bosentan May Reduce Skin Fibrosis in Scleroderma : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 9, 2011 at 6:24 pm By:
Bob Finn - Medical News Net Health News
Scleroderma: Small study suggests benefits from bosentan for skin fibrosis. Sharon Worcester reports http://bit.ly/iqiCVz
Pediatrics Medical News about Hypertension, Pulmonary
mdlinx.com — “Use of Bosentan in neonatal post cardiac surgery pulmonary hypertension” View full resource at mdlinx.com
Most Recently Shared on January 4, 2010 at 10:15 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Peds: Use of Bosentan in neonatal post cardiac surgery pulmonary hypertension: The Annals of Pediatric Cardiology http://url4.eu/13BUE
Cardiology Medical News about Angina Pectoris
mdlinx.com — “First Report of the Successful Use of Bosentan in Refractory Vasospastic Angina” View full resource at mdlinx.com
Most Recently Shared on April 28, 2010 at 1:20 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
First Report of the Successful Use of Bosentan in Refractory Vasospastic Angina: Cardiology http://bit.ly/bMbFIw #cardio #mdlinx
Rheumatology Medical News about Scleroderma, Systemic Sclerosis
mdlinx.com — “Effect of bosentan on skin fibrosis in patients with systemic sclerosis: A prospective, open-label, non-comparative trial” View full resource at mdlinx.com
Most Recently Shared on April 8, 2010 at 8:50 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
#Rheumatology Effect of bosentan on skin fibrosis in patients with systemic sclerosis: A prospective, open-label, ... http://bit.ly/9Uml9w
Rheumatology Medical News about Scleroderma, Systemic
mdlinx.com — “Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 4:05 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary ... http://bit.ly/cjrlMa #Rheumatology
Rheumatology Article |
mdlinx.com — “Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients with systemic sclerosis: IBER-DU Cohort Study” View full resource at mdlinx.com
Most Recently Shared on June 6, 2011 at 8:30 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Bosentan in clinical practice for treating digital and other ischemic ulcers in Spanish patients w... http://bit.ly/kbqQAa #Rheumatology
Rheumatology Article | Scleroderma, Systemic Sclerosis Lung Diseases, Interstitial
mdlinx.com — “Effect of bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: A prospective open-label study” View full resource at mdlinx.com
Most Recently Shared on September 12, 2011 at 10:11 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclo... http://t.co/xyWtsRU #Rheumatology
Cardiology Medical News about Hypertension, Pulmonary
mdlinx.com — “Effective reduction of MCT-PAH by Fasudil. Comparison with Bosentan and Sildenafil” View full resource at mdlinx.com
Most Recently Shared on April 8, 2010 at 7:47 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effective reduction of MCT-PAH by Fasudil. Comparison with Bosentan and Sildenafil: European Respir... http://bit.ly/c2xqL4 #cardio #mdlinx
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
Symposier Cardiology
Symposier.com, the technological platform that will allow you (and your colleagues) to share medical information, and much more with medicine professionals.
-
Skin & Allergy News
The leading independent newspaper for medical, surgical, and aesthetic dermatology.
Advertisement
